Firefly Neuroscience (AIFF) Accounts Payables (2010 - 2026)

Firefly Neuroscience's Accounts Payables history runs 16 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• On a quarterly basis, Accounts Payables fell 17.56% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 17.56% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 25.83% from the prior year.
• Accounts Payables fell to $1.3 million in Q1 2026 per AIFF's latest filing, from $1.3 million in the prior quarter.
• Across five years, Accounts Payables topped out at $1.8 million in Q4 2024 and bottomed at $227560.0 in Q3 2022.
• The 5-year median for Accounts Payables is $839711.0 (2023), against an average of $993201.2.
• Across the five-year window, Accounts Payables plunged 75.44% in 2022 and surged 188.25% in 2024, its largest moves.
• Year by year, Accounts Payables stood at $573789.0 in 2022, then advanced by 9.8% to $630000.0 in 2023, then jumped by 188.25% to $1.8 million in 2024, then fell by 25.83% to $1.3 million in 2025, then fell by 1.34% to $1.3 million in 2026.
• Per Business Quant, the three latest AIFF Accounts Payables figures stand at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025).